Global Urinalysis Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The Urinalysis Market size is expected to reach USD 8.06 Billion in 2034 from USD 4.62 Billion (2025) growing at a CAGR of 6.39% during 2026-2034.

The global urinalysis market is experiencing consistent growth driven by the increasing incidence of chronic diseases such as diabetes, kidney disorders, and urinary tract infections. Urinalysis remains one of the most commonly used diagnostic tests due to its non-invasive nature and cost-effectiveness. The growing emphasis on preventive healthcare and routine health check-ups has significantly boosted the adoption of urinalysis across hospitals, diagnostic laboratories, and home care settings.

Technological advancements, including automated analyzers and digital testing solutions, are major drivers of market expansion. The integration of artificial intelligence and data analytics into diagnostic processes is improving accuracy and efficiency. Additionally, the rising geriatric population, which is more susceptible to urinary and renal conditions, is further fueling demand for reliable diagnostic solutions worldwide.

In the future, the market is expected to benefit from the increasing adoption of point-of-care testing and home-based diagnostic kits. Developing regions are likely to witness rapid growth due to expanding healthcare access and awareness. Continuous innovation in diagnostic technologies and the growing trend of personalized healthcare will further strengthen the market's growth trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Testing Type

Urine Biochemistry Testing
Urine Sediment Testing

By Product

Instruments
Consumables

By Modality

Portable
Standalone
Table Top
Bench Top
Others

By Application

Urinary Tract Infections
Kidney Diseases
Diabetes
Liver Diseases
Pregnancy and Fertility
Others

By End User

Hospital
Laboratory
Home Care Setting
Others

COMPANIES PROFILED

Abbott, Siemens Healthineers, Becton Dickinson and Company BD, Thermo Fisher Scientific Inc, BioRad Laboratories Inc, F HoffmannLa Roche Ltd, Beckman Coulter Inc, ACON Laboratories Inc, Arkray Inc, Trinity Biotech, Quidel Corporation
We can customise the report as per your requirements.

Product Code: VMR11214587

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL URINALYSIS MARKET: BY TESTING TYPE 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Testing Type
4.2. Urine Biochemistry Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Urine Sediment Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL URINALYSIS MARKET: BY PRODUCT 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Product
5.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL URINALYSIS MARKET: BY MODALITY 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Modality
6.2. Portable Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Standalone Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Table Top Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Bench Top Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL URINALYSIS MARKET: BY APPLICATION 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast Application
7.2. Urinary Tract Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Kidney Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.5. Liver Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.6. Pregnancy and Fertility Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL URINALYSIS MARKET: BY END USER 2022-2034 (USD MN)

8.1. Market Analysis, Insights and Forecast End User
8.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.3. Laboratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.4. Home Care Setting Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL URINALYSIS MARKET: BY REGION 2022-2034 (USD MN)

9.1. Regional Outlook
9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.2.1 By Testing Type
- 9.2.2 By Product
- 9.2.3 By Modality
- 9.2.4 By Application
- 9.2.5 By End User
- 9.2.6 United States
- 9.2.7 Canada
- 9.2.8 Mexico
9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.3.1 By Testing Type
- 9.3.2 By Product
- 9.3.3 By Modality
- 9.3.4 By Application
- 9.3.5 By End User
- 9.3.6 United Kingdom
- 9.3.7 France
- 9.3.8 Germany
- 9.3.9 Italy
- 9.3.10 Russia
- 9.3.11 Rest Of Europe
9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.4.1 By Testing Type
- 9.4.2 By Product
- 9.4.3 By Modality
- 9.4.4 By Application
- 9.4.5 By End User
- 9.4.6 India
- 9.4.7 Japan
- 9.4.8 South Korea
- 9.4.9 Australia
- 9.4.10 South East Asia
- 9.4.11 Rest Of Asia Pacific
9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.5.1 By Testing Type
- 9.5.2 By Product
- 9.5.3 By Modality
- 9.5.4 By Application
- 9.5.5 By End User
- 9.5.6 Brazil
- 9.5.7 Argentina
- 9.5.8 Peru
- 9.5.9 Chile
- 9.5.10 Rest of Latin America
9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.6.1 By Testing Type
- 9.6.2 By Product
- 9.6.3 By Modality
- 9.6.4 By Application
- 9.6.5 By End User
- 9.6.6 Saudi Arabia
- 9.6.7 UAE
- 9.6.8 Israel
- 9.6.9 South Africa
- 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

10.1. Recent Developments
10.2. Company Categorization
10.3. Supply Chain & Channel Partners (based on availability)
10.4. Market Share & Positioning Analysis (based on availability)
10.5. Vendor Landscape (based on availability)
10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL URINALYSIS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Company Profiles
- 11.2.1 Abbott
- 11.2.2 Siemens Healthineers
- 11.2.3 Becton Dickinson And Company (BD)
- 11.2.4 Thermo Fisher Scientific Inc
- 11.2.5 Bio-Rad Laboratories Inc
- 11.2.6 F. Hoffmann-La Roche Ltd
- 11.2.7 Beckman Coulter Inc
- 11.2.8 ACON Laboratories Inc
- 11.2.9 Arkray Inc
- 11.2.10 Trinity Biotech
- 11.2.11 Quidel Corporation